The CLLAN Community Forum is a closed forum available by invitation to members of the CLL Advocates Network and participants of the 2019 CLL Horizons Conference. The CLL Advocates Network Forum is run by the volunteer steering committee. It is meant to be a place where other CLL advocates can communicate and share with each other. It is a private forum, open exclusively to the above mentioned target groups. Information on this site is meant for educational purposes only and is not meant to replace or give medical advice. We reserve the right to delete any post without explanation. No liability, explicit or implied, shall be extended to the owners or maintainers of this forum for messages posted to the forum.

We are open to suggestions about what our users want. It is your forum – let us know what improvements you would like to see!

Your CLL Advocates Network Team

Home Forums Covid-19 – Ways you are helping your members Protecting chronic patiens during Covid-19 pandemic

Viewing 1 post (of 1 total)
  • Author
  • #1499

    Diagnoza leukemie patient society has its representative (on behalf of blood cancer patients) within the Patient Advisory Board of the Czech Minister of Health. Together with patient advocates representing vulnerable population (rare diseases, cancer, and chronically ill patients) we have pushed for providing patients with respirators type 2 at specific centres of treatment. Also, some quantities to be at the disposal of patient organisations for use of CLL patients in acute need of personal consultation with their treating doctor.
    Fundraising activities currently in process for Diagnoza leukemie to cover the cost of commercial delivery service of CLL oral therapies to CLL patients living single, i.e. without a caregiver who could pick up their supply of medicine at the clinic. Anti-cancer drugs are not subject of e-prescription in the Czech Republic, they are handed over in person at the respective treatment center.

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.